dr. abou-alfa on the ongoing impact and role of regorafenib in hcc
Published 6 years ago • 64 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:58
dr. abou-alfa on significance of resorce trial for hcc
-
2:05
dr. ghassan abou-alfa on second-line regorafenib in hcc
-
1:27
dr. abou-alfa discusses the storm trial in hcc
-
1:33
dr. abou-alfa on trials investigating immunotherapy in hcc
-
2:04
dr. abou-alfa on key trends in hcc research
-
1:01
potential impact of regorafenib in patients with hcc
-
1:22
dr. abou-alfa on ly2157299 in hcc
-
2:02:07
what about infectious complications after kidney transplantation in africa - english language
-
0:49
dr. daniele on impact of regorafenib in hcc
-
2:28
dr. abou-alfa discusses results of the celestial trial in advanced hcc
-
1:08
dr. abou-alfa on sequencing agents in the treatment of patients with hcc
-
1:43
dr. ghassan abou-alfa on met inhibition with tivantinib and cabozantinib in liver cancer
-
1:00
dr. ghassan abou-alfa on possible second-line treatments for hcc patients
-
1:40
dr. ghassan abou-alfa on doxorubicin plus sorafenib in liver cancer
-
1:38
dr. abou-alfa on adjuvant sorafenib for the treatment of hcc (phase iii storm trial)
-
19:49
late-stage disease - ghassan k. abou-alfa, md
-
1:44
dr. abou-alfa on key eligibility criteria for the proof trial in cholangiocarcinoma
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
1:20
dr. abou-alfa discusses treatment options in liver cancer